Approval in moderate-to-severe patients was based on pivotal trial results showing over four times more Dupixent patients experienced sustained disease remission through Week 36 compared with placebo ...

Sanofi and Regeneron’s Dupixent approved in Japan as the first targeted medicine to treat adults with bullous pemphigoid Approval in moderate-to-severe patients was based on pivotal study results ...

Approval in moderate-to-severe patients was based on pivotal trial results showing over four times more Dupixent patients experienced sustained disease remission through Week 36 compared with placebo ...

Sanofi and Regeneron's Dupixent approved in Japan as the first targeted medicine to treat adults with bullous pemphigoid Approval in moderate-to-severe patients was based on pivotal study results show ...

This week Dr Ray O’Connor takes a look at the potential role of medication and vaccination on the prevention of dementia and ...

After generating interest from the likes of Pfizer and GSK, Quotient Therapeutics’ somatic genomics platform has attracted ...

In this article, we will look at the 12 Best UK Stocks to Buy According to Hedge Funds. UK equities have spent much of the ...

Dhaka, March 24 -- Dhaka, the densely populated capital of Bangladesh, ranked fourth among the world's most polluted cities on Tuesday morning, recording an Air Quality Index (AQI) of 155 at 9:56 am.

SinoMab (03681.HK) Achieves Approximately 43.3% Year-over-Year Decrease in Annual Losses for 2025, Marking Significant Progress in Pipeline Advancement ...

It’s time once again for Fierce Pharma Marketing’s annual #FierceMadness tournament. This time around, we're watching 64 ...

GLP-1 therapies have expanded beyond diabetes and obesity treatment, displaying vascular and potential mental health benefits ...

After illness, the boundaries of daily life contract almost imperceptibly. A trip that once felt routine — like driving to ...